Pacemaker Implantation Procedure and Complications

Procedural Overview

The American College of Cardiology states that pacemaker implantation is a commonly performed, relatively low-risk invasive procedure that typically uses a percutaneous transvenous approach without general anesthesia, though it carries definite risks of both immediate and long-term complications that must be discussed with patients before proceeding 1

The American College of Cardiology recommends the transvenous approach as the standard method, involving percutaneous venous access to advance leads into the right atrium and/or right ventricle, with the pulse generator placed in a subcutaneous or submuscular pocket 2
The epicardial approach may be necessary in very small patients, those with abnormal venous/intracardiac anatomy, or when transvenous access is contraindicated, though this requires sternotomy or thoracotomy with higher lead failure rates 3, 2

Cardiac perforation/tamponade occurs in approximately 1-4% of cases and represents a life-threatening complication requiring immediate recognition, according to the American College of Cardiology 1
Lead failure is more common with epicardial systems compared to transvenous leads, as reported in Circulation 3

The American College of Cardiology notes that ventricular dysfunction may develop years or decades after implantation due to pacemaker-induced dyssynchrony or myocardial autoimmune disease, requiring periodic ventricular function monitoring 2, 4
Paradoxical embolism risk exists in patients with residual intracardiac defects when transvenous leads are used, according to the American College of Cardiology 2, 4

The European Heart Journal warns that electrocautery causes the most common hospital-based interference, potentially resulting in reprogramming, inhibition, noise reversion mode, and myocardial injury from electrode heating 5, 6
MRI is generally contraindicated unless the device is specifically MRI-conditional, as magnetic fields can cause conductor coil heating and electrode tip damage, according to the European Heart Journal 5, 7

A thorough shared decision-making discussion must occur before implantation, addressing the patient's health goals, preferences, values, and individualized risks based on comorbidities and prognosis, as recommended by the American College of Cardiology 8, 1
The American College of Cardiology advises excluding digitalis toxicity as cardioversion or device implantation in this setting can precipitate difficult-to-terminate ventricular arrhythmias 9

Immediate device interrogation is required to verify appropriate function and programming, according to the European Heart Journal 9
Continuous cardiac monitoring should continue until stable pacemaker function is confirmed, as recommended by the American College of Cardiology 1
Driving restrictions typically last 1 week post-implantation unless additional disabling factors exist, according to the European Heart Journal 5, 6

The American College of Cardiology states that quality of life improves substantially after pacemaker implantation in patients with appropriate indications, though benefits of dual-chamber versus single-chamber pacing on quality of life are inconsistent across studies 8, 1